Charles Schwab’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-280,904
| Closed | -$16.8M | – | 3273 |
|
|
2019
Q4 | $16.8M | Buy |
280,904
+7,274
| +3% | +$435K | 0.01% | 1335 |
|
|
2019
Q3 | $7.69M | Buy |
273,630
+48,508
| +22% | +$1.36M | ﹤0.01% | 1756 |
|
|
2019
Q2 | $8.52M | Buy |
225,122
+21,158
| +10% | +$801K | 0.01% | 1700 |
|
|
2019
Q1 | $7.96M | Buy |
203,964
+8,271
| +4% | +$323K | 0.01% | 1729 |
|
|
2018
Q4 | $4.17M | Buy |
195,693
+24,960
| +15% | +$532K | ﹤0.01% | 1997 |
|
|
2018
Q3 | $6.76M | Buy |
170,733
+103,073
| +152% | +$4.08M | ﹤0.01% | 1877 |
|
|
2018
Q2 | $2.59M | Buy |
67,660
+22,063
| +48% | +$843K | ﹤0.01% | 2294 |
|
|
2018
Q1 | $1.37M | Buy |
45,597
+11,000
| +32% | +$331K | ﹤0.01% | 2431 |
|
|
2017
Q4 | $1.08M | Buy |
34,597
+8,997
| +35% | +$281K | ﹤0.01% | 2487 |
|
|
2017
Q3 | $718K | Hold |
25,600
| – | – | ﹤0.01% | 2612 |
|
|
2017
Q2 | $490K | Buy |
25,600
+14,900
| +139% | +$285K | ﹤0.01% | 2697 |
|
|
2017
Q1 | $183K | Hold |
10,700
| – | – | ﹤0.01% | 2942 |
|
|
2016
Q4 | $196K | Buy |
+10,700
| New | +$196K | ﹤0.01% | 2967 |
|